Ekso Bionics Holdings, Inc. Quarterly report [Sections 13 or 15(d)]

Quarterly report [Sections 13 or 15(d)]

Note 3 - Accumulated Other Comprehensive (Loss) Income (Tables)

Note 3 - Accumulated Other Comprehensive (Loss) Income (Tables)

6 Months Ended

Jun. 30, 2025

Notes Tables

Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]

		Three Months Ended June 30,
		2025				2024
Balance at beginning of period		$	424			$	447
Net unrealized (loss) gain on foreign currency translation			(1,107	)			92
Balance at end of period		$	(683	)		$	539

		*Six Months Ended June 30,*
		*2025*				*2024*
Balance at beginning of period		$	957			$	156
Net unrealized (loss) gain on foreign currency translation			(1,640	)			383
Balance at end of period		$	(683	)		$	539